104 related articles for article (PubMed ID: 7971603)
1. [Function of the peritoneum in hyperglycemic conditions].
Czyzewska K
Postepy Hig Med Dosw; 1994; 48(3):291-307. PubMed ID: 7971603
[TBL] [Abstract][Full Text] [Related]
2. [Alternative dialysis solutions in continuous ambulatory peritoneal dialysis].
Olszowska A; Baczyński D
Pol Merkur Lekarski; 1998 Nov; 5(29):307-9. PubMed ID: 10101509
[TBL] [Abstract][Full Text] [Related]
3. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
4. Effects of glucose-free dialysis solutions on human peritoneal mesothelial cells.
Chang JM; Lin SP; Lai YH; Chen HC
Am J Nephrol; 2007; 27(2):206-11. PubMed ID: 17377374
[TBL] [Abstract][Full Text] [Related]
5. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
de Fijter CW; Verbrugh HA; Peters ED; Oe PL; van der Meulen J; Verhoef J; Donker AJ
Clin Nephrol; 1993 Feb; 39(2):75-80. PubMed ID: 8448921
[TBL] [Abstract][Full Text] [Related]
6. The effects of electrolyte, lactate, high-concentrated glucose, and dialysate on peritoneal mesothelial cells.
Takeda K; Nakamoto M; Yasunaga C; Nishihara G; Matsuo K; Urabe M; Goya T
Adv Perit Dial; 1996; 12():11-4. PubMed ID: 8865863
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
[TBL] [Abstract][Full Text] [Related]
8. Glucose and mannitol have different effects on peritoneal morphology in chronically dialyzed rats.
Styszynski A; Kwiatkowska B; Wieczorowska-Tobis K; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2003; 19():15-9. PubMed ID: 14763027
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.
Zheng Z; Ye R; Yu X; Bergström J; Lindholm B
Adv Perit Dial; 2001; 17():53-7. PubMed ID: 11510297
[TBL] [Abstract][Full Text] [Related]
10. Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solution.
van Westrhenen R; Vlijm A; Hiralall JK; Krediet RT
Perit Dial Int; 2008 Nov; 28 Suppl 5():S43-7. PubMed ID: 19008540
[TBL] [Abstract][Full Text] [Related]
11. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
12. Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids.
Yamamoto T; Tomo T; Okabe E; Namoto S; Suzuki K; Hirao Y
Nephrol Dial Transplant; 2009 May; 24(5):1436-42. PubMed ID: 19033251
[TBL] [Abstract][Full Text] [Related]
13. Re: effects of low-glucose degradation product solution on peritoneal membrane characteristics in peritoneal dialysis patients: a 3-year follow-up study.
Ahmadi F
Iran J Kidney Dis; 2014 Mar; 8(2):158-60. PubMed ID: 24685741
[No Abstract] [Full Text] [Related]
14. Effect of the dialysate effluent from CAPD patients on peritoneal mesothelial cells and fibroblasts.
Breborowicz A; Patrikarea A; Martis L; Oreopoulos DG
Adv Perit Dial; 1994; 10():230-4. PubMed ID: 7999835
[TBL] [Abstract][Full Text] [Related]
15. Protecting the peritoneal membrane in dialyzed patients.
Grzegorzewska AE
Adv Med Sci; 2006; 51():191-6. PubMed ID: 17357307
[TBL] [Abstract][Full Text] [Related]
16. PD: a biological membrane and a non-biological fluid.
Jörres A
Contrib Nephrol; 2003; (140):1-9. PubMed ID: 12800338
[No Abstract] [Full Text] [Related]
17. Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum.
Duman S; Wieczorowska-Tobis K; Styszynski A; Kwiatkowska B; Breborowicz A; Oreopoulos DG
Adv Perit Dial; 2004; 20():31-6. PubMed ID: 15384791
[TBL] [Abstract][Full Text] [Related]
18. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
19. Effects of bicarbonate dialysis solution on peritoneal transport in rats.
Suzuki K; Khanna R; Nolph KD; Moore HL; Twardowski ZJ
Adv Perit Dial; 1996; 12():24-6. PubMed ID: 8865866
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
